IL-1β and IL-18 also contribute to adipose tissue inflammation and insulin resistance, and the significant reduction in their mRNA levels following CGWE treatment indicates its potential to mitigate these inflammatory pathways and improve metabolic health in obese individuals. This evidence concerns the gene IL18 and Insulin resistance.